Study of SkQ1 as Treatment for Dry-eye Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

452

Participants

Timeline

Start Date

December 6, 2018

Primary Completion Date

February 9, 2019

Study Completion Date

February 9, 2019

Conditions
Dry Eye Syndrome
Interventions
DRUG

Low Dose - SkQ1

SkQ1 Low dose ophthalmic solution

DRUG

High dose - SkQ1

SkQ1 High Dose ophthalmic solution

DRUG

SkQ1 (Vehicle)

Vehicle for SkQ1 ophthalmic solution

Trial Locations (7)

28150

Vita Eye Clinic, Shelby

38119

Total Eye Care, PA, Memphis

40206

Eye Care Insititute, Louisville

85032

Cornea & Cataract Consultants of Arizona, Phoenix

92663

Eye Research Foundation, Newport Beach

04240

Central Maine Eye Care, Lewiston

01810

Andover Eye Associates, Andover

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

ORA, Inc.

INDUSTRY

lead

Mitotech, SA

INDUSTRY